GUTS stock news · Fractyl Health, Inc.
Get alerts for GUTS
Follow Fractyl Health, Inc. (GUTS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GUTSFractyl Health added Michael Wartell as a new director and shared details about his pay.
NeutralFractyl Health added Michael Wartell as an independent director, with $40,000 monthly pay plus extra fees. His experience may aid oversight, but this does not change the company's outlook.
Fractyl Health, Inc. will spend about $2 million to cut jobs and close some operations.
Bad for GUTSFractyl Health plans to cut about 45% of its workforce and stop developing Rejuva internally. Its focus on Revita does not outweigh the lost program and deep cuts, so the filing is unfavorable.
12 health care stocks are changing a lot during Friday's trading.
NeutralFractyl Health shares fell 58.4% to $1.73, but the article gives no business news behind the move. It does not change the company's outlook.
Fractyl Health's stock dropped almost 50% on Friday despite good news about its weight-loss treatment.
NeutralFractyl said its weight-loss treatment met the study's main goal, but a lawsuit and earlier disappointing results complicate the picture. Together, the news leaves its outlook mixed.
12 health care stocks are changing a lot before the market opens on Friday.
NeutralFractyl Health shares fell 44.2% in Friday's pre-market session. The article gives no company news, so this does not change its business outlook.
Fractyl Health, Inc. shares important news about its weight loss study results.
Good for GUTSFractyl Health reported that Revita helped people keep more weight off 6 months after stopping GLP-1 treatment. The study met its main goal, supporting the company's prospects.